Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 3, 2002, Pages 149-164

  Li, Huige ^a   Wallerath, Thomas ^a   Münzel, Thomas ^b   Förstermann, Ulrich ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ACE inhibitors; AT1 receptor antagonists; Atherosclerosis; Diabetes; Endothelial dysfunction; eNOS uncoupling; Glucocorticoids; Hypertension; Oxidative stress; Statins; Staurosporine

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STATIN; SUPEROXIDE; TACROLIMUS;

ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG EFFECT; DRUG RESPONSE; DRUG TARGETING; ENZYME REGULATION; GENE EXPRESSION REGULATION; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOXIA; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REDUCTION; REPERFUSION INJURY; REVIEW; STROKE;

ANIMALS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HUMANS; METABOLIC DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III;

GOES;

EID: 0036430356     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00111-8     Document Type: Review

References (201)

1. H. Li, T. Wallerath, U. Förstermann, Physiological mechanisms regulating the expression of endothelial-type NO synthase, Nitric Oxide Biol. Chem. 7 (2002) 103-118.
2. K. Hirata, N. Miki, Y. Kuroda, T. Sakoda, S. Kawashima, M. Yokoyama, Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells, Circ. Res. 76 (1995) 958-962.
3. J.K. Liao, W.S. Shin, W.Y. Lee, S.L. Clark, Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase, J. Biol. Chem. 270 (1995) 319-324.
4. F. Vidal, C. Colome, J. Martinez Gonzalez, L. Badimon, Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells, Eur. J. Biochem. 252 (1998) 378-384.
5. J. Martinez-Gonzalez, B. Raposo, C. Rodriguez, L. Badimon, 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: Balance between transcriptional and posttranscriptional regulation, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 804-809.
6. O. Hernandez-Perera, D. Perez-Sala, J. Navarro-Antolin, R. Sanchez-Pascuala, G. Hernandez, C. Diaz, S. Lamas, Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells, J. Clin. Invest. 101 (1998) 2711-2719.
7. K. Kanazawa, S. Kawashima, S. Mikami, Y. Miwa, K. Hirata, M. Suematsu, Y. Hayashi, H. Itoh, M. Yokoyama, Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation, Am. J. Pathol. 148 (1996) 1949-1956.
8. H. Kano, T. Hayashi, D. Sumi, T. Esaki, Y. Asai, N.K. Thakur, M. Jayachandran, A. Iguchi, A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: Possible relevance of upregulation of endothelial NO synthase mRNA, Biochem. Biophys. Res. Commun. 259 (1999) 414-419.
9. T.E. Peterson, V. Poppa, H. Ueba, A. Wu, C. Yan, B.C. Berk, Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae, Circ. Res. 85 (1999) 29-37.
10. H. Cai, D.G. Harrison, Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress, Circ. Res. 87 (2000) 840-844.
11. R.J. Coppinger, C.L. Baum, Cholesterol-dependent regulation of nitric oxide production: Potential role in atherosclerosis, Nutr. Rev. 57 (1999) 279-282.
12. J.N. Wilcox, R.R. Subramanian, C.L. Sundell, W.R. Tracey, J.S. Pollock, D.G. Harrison, P.A. Marsden, Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels, Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2479-2488.
13. B.S. Oemar, M.R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, T.F. Lüscher, Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis, Circulation 97 (1998) 2494-2498.
14. L.D. Buttery, A.H. Chester, D.R. Springall, J.A. Borland, T. Michel, M.H. Yacoub, J.M. Polak, Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites, J. Pathol. 179 (1996) 197-203.
15. J.M. Stulak, A. Lerman, J.A. Caccitolo, S.H. Wilson, J.C. Romero, H.V. Schaff, M.R. Porcel, L.O. Lerman, Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia, Atherosclerosis 154 (2001) 195-201.
16. S.H. Wilson, R.D. Simari, P.J. Best, T.E. Peterson, L.O. Lerman, M. Aviram, K.A. Nath, D.R. Holmes, A. Lerman, Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 122-128.
17. M. Schwemmer, O. Sommer, R. Koeckerbauer, E. Bassenge, Cardiovascular dysfunction in hypercholesterolemia associated with enhanced formation of AT1-receptor and of eicosanoids, J. Cardiovasc. Pharmacol. Ther. 5 (2000) 59-68.
18. S. Verma, T.J. Anderson, Fundamentals of endothelial function for the clinical cardiologist, Circulation 105 (2002) 546-549.
19. U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, M. Hartmann, M. Skatchkov, F. Thaiss, R.A. Stahl, A. Warnholtz, T. Meinertz, K. Griendling, D.G. Harrison, U. Forstermann, T. Münzel, Mechanisms underlying endothelial dysfunction in diabetes mellitus, Circ. Res. 88 (2001) E14-E22.
20. T. Kobayashi, K. Kamata, Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats, Atherosclerosis 155 (2001) 313-320.
21. S.J. Shin, F.J. Lai, J.D. Wen, P.J. Hsiao, M.C. Hsieh, T.F. Tzeng, H.C. Chen, J.Y. Guh, J.H. Tsai, Neuronal and endothelial nitric oxide synthase expression in outer medulla of streptozotocin-induced diabetic rat kidney, Diabetologia 43 (2000) 649-659.
22. A.M. Joussen, V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S.J. Wiegand, J. Rudge, G.D. Yancopoulos, A.P. Adamis, Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo, Am. J. Pathol. 160 (2002) 501-509.
23. M. Takeda, F. Mori, A. Yoshida, A. Takamiya, S. Nakagomi, E. Sato, H. Kiyama, Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats, Diabetologia 44 (2001) 1043-1050.
24. F. Cosentino, K. Hishikawa, Z.S. Katusic, T.F. Lüscher, High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation 96 (1997) 25-28.
25. Y. Ding, N.D. Vaziri, R. Coulson, V.S. Kamanna, D.D. Roh, Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression, Am. J. Physiol. 279 (2000) E11-E17.
26. U. Chakravarthy, R.G. Hayes, A.W. Stitt, E. McAuley, D.B. Archer, Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products, Diabetes 47 (1998) 945-952.
27. J.A. Barbera, V.I. Peinado, S. Santos, J. Ramirez, J. Roca, R. Rodriguez-Roisin, Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers, Am. J. Respir. Crit. Care. Med. 164 (2001) 709-713.
28. X.L. Wang, A.S. Sim, M.X. Wang, G.A. Murrell, B. Trudinger, J. Wang, Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity, FEBS Lett. 471 (2000) 45-50.
29. Y. Su, W. Han, C. Giraldo, Y. De Li, E.R. Block, Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells, Am. J. Respir. Cell. Mol. Biol. 19 (1998) 819-825.
30. J.L. Wright, J. Dai, K. Zay, K. Price, C.B. Gilks, A. Churg, Effects of cigarette smoke on nitric oxide synthase expression in the rat lung, Lab. Invest. 79 (1999) 975-983.
31. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, M.C. Fishman, Hypertension in mice lacking the gene for endothelial nitric oxide synthase, Nature 377 (1995) 239-242.
32. Y. Ohashi, S. Kawashima, K.-i. Hirata, T. Yamashita, T. Ishida, N. Inoue, T. Sakoda, H. Kurihara, Y. Yazaki, M. Yokoyama, Hypotension and reduced nitric oxide-†elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase, J. Clin. Invest. 102 (1998) 2061-2071.
33. D.D. Rees, R.M. Palmer, S. Moncada, Role of endothelium-derived nitric oxide in the regulation of blood pressure, Proc. Natl. Acad. Sci. USA 86 (1989) 3375-3378.
34. R.D. Rudic, E.G. Shesely, N. Maeda, O. Smithies, S.S. Segal, W.C. Sessa, Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling, J. Clin. Invest. 101 (1998) 731-736.
35. K.F. Lin, L. Chao, J. Chao, Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery, Hypertension 30 (1997) 307-313.
36. H. Takase, M. Sugiyama, A. Nakazawa, K. Sato, R. Ueda, Y. Dohi, Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension, Arzneimittelforschung 50 (2000) 530-534.
37. R.P. Lifton, A.G. Gharavi, D.S. Geller, Molecular mechanisms of human hypertension, Cell 104 (2001) 545-556.
38. D.L. Garbers, S.K. Dubois, The molecular basis of hypertension, Annu. Rev. Biochem. 68 (1999) 127-155.
39. G. Zalba, G. San Jose, M.U. Moreno, M.A. Fortuno, A. Fortuno, F.J. Beaumont, J. Diez, Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase, Hypertension 38 (2001) 1395-1399.
40. C. Berry, M.J. Brosnan, J. Fennell, C.A. Hamilton, A.F. Dominiczak, Oxidative stress and vascular damage in hypertension, Curr. Opin. Nephrol. Hypertens. 10 (2001) 247-255.
41. S. Kerr, M.J. Brosnan, M. Mclntyre, J.L. Reid, A.F. Dominiczak, C.A. Hamilton, Superoxide anion production is increased in a model of genetic hypertension: Role of the endothelium, Hypertension 33 (1999) 1353-1358.
42. N.D. Vaziri, Y. Ding, Z. Ni, Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug, J. Pharmacol. Exp. Ther. 298 (2001) 679-685.
43. W. Steudel, F. Ichinose, P.L. Huang, W.E. Hurford, R.C. Jones, J.A. Bevan, M.C. Fishman, W.M. Zapol, Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene, Circ. Res. 81 (1997) 34-41.
44. J.R. Fineman, J. Wong, F.C. Morin 3rd, L.M. Wild, S.J. Soifer, Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs, J. Clin. Invest. 93 (1994) 2675-2683.
45. K.A. Fagan, B.W. Fouty, R.C. Tyler, K.G. Morris Jr., L.K. Hepler, K. Sato, T.D. LeCras, S.H. Abman, H.D. Weinberger, P.L. Huang, I.F. McMurtry, D.M. Rodman, The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia, J. Clin. Invest. 103 (1999) 291-299.
46. S.P. Janssens, K.D. Bloch, Z. Nong, R.D. Gerard, P. Zoldhelyi, D. Collen, Adeno viral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats, J. Clin. Invest. 98 (1996) 317-324.
47. A. Giaid, D. Saleh, Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension, N. Engl. J. Med. 333 (1995) 214-221.
48. N.A. Mason, D.R. Springall, M. Burke, J. Pollock, G. Mikhail, M.H. Yacoub, J.M. Polak, High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension, J. Pathol. 185 (1998) 313-318.
49. P.W. Shaul, I.S. Yuhanna, Z. German, Z. Chen, R.H. Steinhorn, F.C. Morin 3rd, Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension, Am. J. Physiol. 272 (1997) L1005-L1012.
50. E. Villamor, T.D. Le Cras, M.P. Koran, A.C. Halbower, R.M. Tuder, S.H. Abman, Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus, Am. J. Physiol. 272 (1997) L1013-L1020.
51. T.D. Le Cras, D.H. Kim, N.E. Markham, A.S. Abman, Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude, Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L283-L291.
52. R.C. Tyler, M. Muramatsu, S.H. Abman, T.J. Stelzner, D.M. Rodman, K.D. Bloch, I.F. McMurtry, Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension, Am. J. Physiol. 276 (1999) L297-L303.
53. S. Kanno, Y.J. Wu, P.C. Lee, T.R. Billiar, C. Ho, Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats, Circulation 104 (2001) 945-950.
54. T.R. Quinlan, D. Li, V.E. Laubach, E.G. Shesely, N. Zhou, R.A. Johns, eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia, Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L641-L650.
55. Z.G. Zhang, M. Chopp, C. Zaloga, J.S. Pollock, U. Förstermann, Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats, Stroke 24 (1993) 2016-2021.
56. Z. Huang, P.L. Huang, J. Ma, W. Meng, C. Ayata, M.C. Fishman, M.A. Moskowitz, Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine, J. Cereb. Blood Flow Metab. 16 (1996) 981-987.
57. S. Kimoto-Kinoshita, S. Nishida, T.T. Tomura, Decrease of endothelial nitric oxide synthase in stroke-prone spontaneously hypertensive rat cerebral cortex, Neurosci. Lett. 288 (2000) 103-106.
58. M. Yamada, Z. Huang, T. Dalkara, M. Endres, U. Laufs, C. Waeber, P.L. Huang, J.K. Liao, M.A. Moskowitz, Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment, J. Cereb. Blood Flow Metab. 20 (2000) 709-717.
59. U. Laufs, M. Endres, N. Stagliano, S. Amin Hanjani, D.S. Chui, S.X. Yang, T. Simoncini, M. Yamada, E. Rabkin, P.G. Allen, P.L. Huang, M. Bohm, F.J. Schoen, M.A. Moskowitz, J.K. Liao, Neuroprotection mediated by changes in the endothelial actin cytoskeleton, J. Clin. Invest. 106 (2000) 15-24.
60. C.J. Vaughan, N. Delanty, Neuroprotective properties of statins in cerebral ischemia and stroke, Stroke 30 (1999) 1969-1973.
61. C.J. Smith, D. Sun, C. Hoegler, B.S. Roth, X. Zhang, G. Zhao, X.B. Xu, Y. Kobari, K. Pritchard Jr., W.C. Sessa, T.H. Hintze, Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure, Circ. Res. 78 (1996) 58-64.
62. L. Comini, T. Bachetti, G. Gaia, E. Pasini, L. Agnoletti, P. Pepi, C. Ceconi, S. Curello, R. Ferrari, Aorta and skeletal muscle NO synthase expression in experimental heart failure, J. Mol. Cell. Cardiol. 28 (1996) 2241-2248.
63. L. Agnoletti, S. Curello, T. Bachetti, F. Malacarne, G. Gaia, L. Comini, M. Volterrani, P. Bonetti, G. Parrinello, M. Cadei, P.G. Grigolato, R. Ferrari, Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: Role of tumor necrosis factor-α, Circulation 100 (1999) 1983-1991.
64. M. Yoshizumi, M.A. Perrella, J.C. Burnett Jr., M.E. Lee, Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life, Circ. Res. 73 (1993) 205-209.
65. B. Stein, T. Eschenhagen, J. Rudiger, H. Scholz, U. Förstermann, I. Gath, Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure, J. Am. Coll. Cardiol. 32 (1998) 1179-1186.
66. R. Ziesche, V. Petkov, W. Mosgoller, L.H. Block, Regulation of human endothelial nitric oxide synthase by hypoxia and inflammation in human pulmonary arteries - Implications for the therapy of pulmonary hypertension in COPD patients, Acta Anaesthesiol. Scand. Suppl. 109 (1996) 97-98.
67. A. Dai, Z. Zhang, R. Niu, The effects of hypoxia on nitric oxide synthase activity and mRNA expression of pulmonary artery endothelial cells in pigs, Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 18 (1995) 164-166.
68. J.K. Liao, J.J. Zulueta, F.S. Yu, H.B. Peng, C.G. Cote, P.M. Hassoun, Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen, J. Clin. Invest. 96 (1995) 2661-2666.
69. A.J. North, K.S. Lau, T.S. Brannon, L.C. Wu, L.B. Wells, Z. German, P.W. Shaul, Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells, Am. J. Physiol. 270 (1996) L643-L649.
70. L.P. McQuillan, G.K. Leung, P.A. Marsden, S.K. Kostyk, S. Kourembanas, Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms, Am. J. Physiol. 36 (1994) H1921-H1927.
71. U. Laufs, V.L. Fata, J.K. Liao, Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase, J. Biol. Chem. 272 (1997) 31725-31729.
72. M.W. Phelan, D.V. Faller, Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells, J. Cell. Physiol. 167 (1996) 469-476.
73. U.A. Arnet, A. McMillan, J.L. Dinerman, B. Ballermann, C.J. Lowenstein, Regulation of endothelial nitric-oxide synthase during hypoxia, J. Biol. Chem. 271 (1996) 15069-15073.
74. J.M. Justice, M.A. Tanner, P.R. Myers, Endothelial cell regulation of nitric oxide production during hypoxia in coronary microvessels and epicardial arteries, J. Cell. Physiol. 182 (2000) 359-365.
75. M. Toporsian, K. Govindaraju, M. Nagi, D. Eidelman, G. Thibault, M.E. Ward, Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo, Circ. Res. 86 (2000) 671-675.
76. T.D. Le Cras, R.C. Tyler, M.P. Horan, K.G. Morris, R.M. Tuder, I.F. McMurtry, R.A. Johns, S.H. Abman, Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung, J. Clin. Invest. 101 (1998) 795-801.
77. T.D. Le Cras, C. Xue, A. Rengasamy, R.A. Johns, Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung, Am. J. Physiol. 270 (1996) L164-L170.
78. P.W. Shaul, A.J. North, T.S. Brannon, K. Ujiie, L.B. Wells, P.A. Nisen, C.J. Lowenstein, S.H. Snyder, R.A. Star, Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung, Am. J. Respir. Cell. Mol. Biol. 13 (1995) 167-174.
79. C. Xue, R.A. Johns, Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat, Hypertension 28 (1996) 743-753.
80. A.T. Demiryurek, M.R. Karamsetty, A.R. McPhaden, R.M. Wadsworth, K.A. Kane, M.R. MacLean, Accumulation of nitrotyrosine correlates with endothelial NO synthase in pulmonary resistance arteries during chronic hypoxia in the rat, Pulm. Pharmacol. Ther. 13 (2000) 157-165.
81. T.C. Resta, L.G. Chicoine, J.L. Omdahl, B.R. Walker, Maintained upregulation of pulmonary eNOS gene and protein expression during recovery from chronic hypoxia, Am. J. Physiol. 276 (1999) H699-H708.
82. T.D. Le Cras, I.F. McMurtry, Nitric oxide production in the hypoxic lung, Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L575-582.
83. R.R. Giraldez, A. Panda, Y. Xia, S.P. Sanders, J.L. Zweier, Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart, J. Biol. Chem. 212 (1997) 21420-21426.
84. H. Chen, D. Li, T. Saldeen, J.L. Mehta, TGF-β(1) modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation, Am. J. Physiol. 281 (2001) H1035-H1039.
85. P. Di Napoli, A. Antonio Taccardi, A. Grilli, R. Spina, M. Felaco, A. Barsotti, R. De Caterina, Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: An ex vivo study in isolated working rat hearts, Cardiovasc. Res. 51 (2001) 283-293.
86. M. Joyce, C.J. Kelly, G. Chen, D.J. Bouchier-Hayes, Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase, Eur. J. Vasc. Endovasc. Surg. 21 (2001) 295-300.
87. M.S. Sumeray, D.D. Rees, D.M. Yellon, Infarct size and nitric oxide synthase in murine myocardium, J. Mol. Cell. Cardiol. 32 (2000) 35-42.
88. M. Gerhard, M.A. Roddy, S.J. Creager, M.A. Creager, Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans, Hypertension 27 (1996) 849-853.
89. M.R. Cernadas, L. Sanchez de Miguel, M. Garcia Duran, F. Gonzalez Fernandez, I. Millas, M. Monton, J. Rodrigo, L. Rico, P. Fernandez, T. de Frutos, J.A. Rodriguez Feo, J. Guerra, C. Caramelo, S. Casado, F. Lopez, Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats, Circ. Res. 83 (1998) 279-286.
90. M. Challah, S. Nadaud, M. Philippe, T. Battle, F. Soubrier, B. Corman, J.B. Michel, Circulating and cellular markers of endothelial dysfunction with aging in rats, Am. J. Physiol. 273 (1997) H1941-H1948.
91. T.C. Chou, M.H. Yen, C.Y. Li, Y.A. Ding, Alterations of nitric oxide synthase expression with aging and hypertension in rats, Hypertension 31 (1998) 643-648.
92. T. Finkel, N.J. Holbrook, Oxidants, oxidative stress and the biology of ageing, Nature 408 (2000) 239-247.
93. B. van der Loo, R. Labugger, J.N. Skepper, M. Bachschmid, J. Kilo, J.M. Powell, M. Palacios-Callender, J.D. Erusalimsky, T. Quaschning, T. Malinski, D. Gygi, V. Ullrich, T.F. Luscher, Enhanced peroxynitrite formation is associated with vascular aging, J. Exp. Med. 192 (2000) 1731-1744.
94. C. Patterson, N.R. Madamanchi, M.S. Runge, The oxidative paradox: Another piece in the puzzle, Circ. Res. 87 (2000) 1074-1076.
95. S. Lopez-Ongil, O. Hernandez-Perera, J. Navarro-Antolin, G. Perez de Lema, M. Rodriguez-Puyol, S. Lamas, D. Rodriguez-Puyol, Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells, Br. J. Pharmacol. 124 (1998) 447-454.
96. G.R. Drummond, H. Cai, M.E. Davis, S. Ramasamy, D.G. Harrison, Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide, Circ. Res. 86 (2000) 347-354.
97. H. Cai, M.E. Davis, G.R. Drummond, D.G. Harrison, Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1571-1576.
98. H. Mollnau, M. Wendt, K. Szöcs, B. Lassegue, E. Schulz, M. Oelze, H. Li, M. Bodenschatz, M. August, A.L. Kleschyov, N. Tsilimingas, U. Walter, U. Förstermann, T. Meinertz, K. Griendling, T. Münzel, Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling, Circ. Res. 90 (2002) e58-e65.
99. T. Münzel, H. Li, H. Mollnau, U. Hink, E. Matheis, M. Hartmann, M. Oelze, M. Skatchkov, A. Warnholtz, L. Duncker, T. Meinertz, U. Förstermann, Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability, Circ. Res. 86 (2000) E7-E12.
100. H. Li, S.A. Oehrlein, T. Wallerath, I. Ihrig-Biedert, P. Wohlfart, T. Ulshöfer, T. Jessen, T. Herget, U. Förstermann, H. Kleinert, Activation of protein kinase C α and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene, Mol. Pharmacol. 53 (1998) 630-637.
101. S.R. Thomas, K. Chen, J.F. Keaney Jr., Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway, J. Biol. Chem. 211 (2002) 6017-6024.
102. H.M. Abu Soud, K. Ichimori, A. Presta, D.J. Stuehr, Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase, J. Biol. Chem. 215 (2000) 17349-17357.
103. P.J. Andrew, B. Mayer, Enzymatic function of nitric oxide synthases, Cardiovasc. Res. 43 (1999) 521-531.
104. B. Mayer, Nitric oxide synthases catalyze superoxide formation, FEBS Lett. 481 (2000) 304.
105. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B.S. Masters, H. Karoui, P. Tordo, K.A. Pritchard Jr., Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors, Proc. Natl. Acad. Sci. USA 95 (1998) 9220-9225.
106. Y. Xia, A.L. Tsai, V. Berka, J.L. Zweier, Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process, J. Biol. Chem. 213 (1998) 25804-25808.
107. E. Stroes, M. Hijmering, M. vanZandvoort, R. Wever, T.J. Rabelink, E.E. vanFaassen, Origin of superoxide production by endothelial nitric oxide synthase, FEES Lett. 438 (1998) 161-164.
108. K.A. Pritchard Jr., L. Groszek, D.M. Smalley, W.C. Sessa, M. Wu, P. Villalon, M.S. Wolin, M.B. Stemerman, Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion, Circ. Res. 77 (1995) 510-518.
109. J.B. Laursen, M. Somers, S. Kurz, L. McCann, A. Warnholtz, B.A. Freeman, M. Tarpey, T. Fukai, D.G. Harrison, Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin, Circulation 103 (2001) 1282-1288.
110. F. Cosentino, S. Patton, L.V. d'Uscio, E.R. Werner, G. Werner Felmayer, P. Moreau, T. Malinski, T.F. Luscher, Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats, J. Clin. Invest. 101 (1998) 1530-1537.
111. G. Werner-Felmayer, E.R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, K. Schmidt, G. Weiss, H. Wachter, Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity, J. Biol. Chem. 268 (1993) 1842-1846.
112. P. Rosenkranz-Weiss, W.C. Sessa, S. Milstien, S. Kaufman, C.A. Watson, J.S. Pober, Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity, J. Clin. Invest. 93 (1994) 2236-2243.
113. G.M. Pieper, Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin, J. Cardiovasc. Pharmacol. 29 (1997) 8-15.
114. K. Shinozaki, Y. Nishio, T. Okamura, Y. Yoshida, H. Maegawa, H. Kojima, M. Masada, N. Toda, R. Kikkawa, A. Kashiwagi, Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats, Circ. Res. 87 (2000) 566-573.
115. E. Stroes, J. Kastelein, F. Cosentino, W. Erkelens, R. Wever, H. Koomans, T. Lüscher, T. Rabelink, Tetrahydrobiopterin restores endothelial function in hypercholesterolemia, J. Clin. Invest. 99 (1997) 41-46.
116. T. Heitzer, C. Brockhoff, B. Mayer, A. Warnholtz, H. Mollnau, S. Henne, T. Meinertz, T. Münzel, Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: Evidence for a dysfunctional nitric oxide synthase, Circ. Res. 86 (2000) E36-E41.
117. S. Milstien, Z. Katusic, Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function, Biochem. Biophys. Res. Commun. 263 (1999) 681-684.
118. 2-imbalance in insulin-resistant rat aorta, Diabetes 48 (1999) 2437-2445.
119. H.-J. Hong, G. Hsiao, T.-H. Cheng, M.-H. Yen, Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats, Hypertension 38 (2001) 1044-1048.
120. A. Faggiotto, R. Paoletti, Statins and blockers of the renin-angiotensin system: Vascular protection beyond their primary mode of action, Hypertension 34 (1999) 987-996.
121. U. Laufs, V. La Fata, J. Plutzky, J.K. Liao, Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation 97 (1998) 1129-1135.
122. U. Laufs, J.K. Liao, Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase, J. Biol. Chem. 273 (1998) 24266-24271.
123. S. Takeuchi, S. Kawashima, Y. Rikitake, T. Ueyama, N. Inoue, K. Hirata, M. Yokoyama, Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC, Biochem. Biophys. Res. Commun. 269 (2000) 97-102.
124. A.H. Wagner, T. Kohler, U. Ruckschloss, I. Just, M. Hecker, Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 61-69.
125. D. Sumi, T. Hayashi, N.K. Thakur, M. Jayachandran, Y. Asai, H. Kano, H. Matsui, A. Iguchi, A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - The relevance of endothelial nitric oxide synthase and superoxide anion scavenging action, Atherosclerosis 155 (2001) 347-357.
126. M. Tannous, R. Cheung, A. Vignini, B. Mutus, Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects, Thromb. Haemost. 82 (1999) 1390-1394.
127. M. Endres, U. Laufs, Z. Huang, T. Nakamura, P. Huang, M.A. Moskowitz, J.K. Liao, Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. USA 95 (1998) 8880-8885.
128. U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Bohm, U. Dirnagl, M. Endres, Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice, Stroke 31 (2000) 2442-2449.
129. S. Amin-Hanjani, N.E. Stagliano, M. Yamada, P.L. Huang, J.K. Liao, M.A. Moskowitz, Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice, Stroke 52 (2001) 980-986.
130. W.H. Kaesemeyer, R.B. Caldwell, J. Huang, R.W. Caldwell, Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions, J. Am. Coll. Cardiol. 33 (1999) 234-241.
131. S. Wassmann, U. Laufs, A.T. Baumer, K. Muller, K. Ahlbory, W. Linz, G. Itter, R. Rosen, M. Bohm, G. Nickenig, HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species, Hypertension 37 (2001) 1450-1457.
132. M. Miyazaki, H. Sakonjo, S. Takai, Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet, Br. J. Pharmacol. 128 (1999) 523-529.
133. N. de las Heras, P. Aragoncillo, R. Maeso, S. Vazquez Perez, J. Navarro Cid, M. DeGasparo, J. Mann, L.M. Ruilope, V. Cachofeiro, V. Lahera, AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits, Hypertension 34 (1999) 969-975.
134. W. Linz, P. Wohlfart, B.A. Scholkens, T. Malinski, G. Wiemer, Interactions among ACE, kinins and NO, Cardiovasc. Res. 43 (1999) 549-561.
135. W. Linz, P. Wohlfart, B.A. Schoelkens, R.H. Becker, T. Malinski, G. Wiemer, Late treatment with ramipril increases survival in old spontaneously hypertensive rats, Hypertension 34 (1999) 291-295.
136. G. Wiemer, W. Linz, S. Hatrik, B.A. Scholkens, T. Malinski, Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats, Hypertension 30 (1997) 1183-1190.
137. T. Bachetti, L. Comini, E. Pasini, A. Cargnoni, S. Curello, R. Ferrari, ACE-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats, J. Mol. Cell. Cardiol. 33 (2001) 395-403.
138. N. Kobayashi, T. Higashi, K. Hara, H. Shirataki, H. Matsuoka, Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats, Cardiovasc. Res. 44 (1999) 518-526.
139. R. Varin, P. Mulder, F. Tamion, V. Richard, J.P. Henry, F. Lallemand, G. Lerebours, C. Thuillez, Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: Role of nitric oxide, prostanoids, oxidant stress, and bradykinin, Circulation 102 (2000) 351-356.
140. M. Kohno, K. Yokokawa, M. Minami, K. Yasunari, K. Maeda, H. Kano, T. Hanehira, J. Yoshikawa, Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension, Metabolism 48 (1999) 1256-1259.
141. R.M. Goetz, J. Holtz, Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: Evidence for a causal link, Clin. Sci. Colch. 97 (1999) 165-174.
142. J.S. Silvestre, S. Bergaya, R. Tamarat, M. Duriez, C.M. Boulanger, B.I. Levy, Proangiogenic effect of angiotensin-converting enzyme inhibition
143. W. Linz, H. Heitsch, B.A. Scholkens, G. Wiemer, Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats, Hypertension 35 (2000) 908-913.
144. T. Higashi, N. Kobayashi, K. Hara, H. Shirataki, H. Matsuoka, Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats, J. Cardiovasc. Pharmacol. 35 (2000) 564-571.
145. N. Kobayashi, Y. Mori, S. Nakano, Y. Tsubokou, T. Kobayashi, H. Shirataki, H. Matsuoka, TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats, Atherosclerosis 158 (2001) 359-368.
146. M.C. Verhaar, M.L. Honing, T. van Dam, M. Zwart, H.A. Koomans, J.J. Kastelein, T.J. Rabelink, Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids, Cardiovasc. Res. 42 (1999) 752-760.
147. J. Yang, K. Fukuo, S. Morimoto, T. Niinobu, T. Suhara, T. Ogihara, Pranidipine enhances the action of nitric oxide released from endothelial cells, Hypertension 35 (2000) 82-85.
148. S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, S. Favilla, A. Pompella, A. Salvetti, Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension, Hypertension 37 (2001) 943-948.
149. S. Taddei, A. Virdis, L. Ghiadoni, S. Uleri, A. Magagna, A. Salvetti, Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients, Hypertension 30 (1997) 1606-1612.
150. S. Dhein, A. Salameh, R. Berkels, W. Klaus, Dual mode of action of dihydropyridine calcium antagonists - A role for nitric oxide, Drugs 58 (1999) 397-404.
151. + channels in rat aorta and brain micro vascular endothelial cells, Am. J. Physiol. 265 (1993) C812-C821.
152. M. Kitakaze, H. Asanuma, S. Takashima, T. Minamino, Y. Ueda, Y. Sakata, M. Asakura, S. Sanada, T. Kuzuya, M. Hori, Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs, Circulation 101 (2000) 311-317.
153. X. Zhang, T.H. Hintze, Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent, Circulation 97 (1998) 576-580.
154. Y. Ding, N.D. Vaziri, Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells, Hypertension 32 (1998) 718-723.
155. X.Q. Wang, N.D. Vaziri, Erythropoietin depresses nitric oxide synthase expression by human endothelial cells, Hypertension 33 (1999) 894-899.
156. Y. Ding, N.D. Vaziri, Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression, J. Pharmacol. Exp. Ther. 292 (2000) 606-609.
157. Z. Ni, X.Q. Wang, N.D. Vaziri, Nitric oxide metabolism in erythropoietin-inducedhypertension: Effect of calcium channel blockade, Hypertension 32 (1998) 724-729.
158. N.D. Vaziri, Z. Ni, X.Q. Wang, F. Oveisi, X.J. Zhou, Down-regulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH, Am. J. Physiol. 274 (1998) F642-F649.
159. T. Yamashita, S. Kawashima, M. Ozaki, Y. Rikitake, T. Hirase, N. Inoue, K. Hirata, M. Yokoyama, A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production, J. Hypertens. 19 (2001) 451-458.
160. N. Kobayashi, K. Kobayashi, K. Hara, T. Higashi, H. Yanaka, S. Yagi, H. Matsuoka, Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats, Am. J. Hypertens. 12 (1999) 483-491.
161. P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, T. Godfraind, Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats, Hypertension 37 (2001) 1124-1128.
162. M. Naruse, A. Tanabe, T. Seki, C. Adachi, T. Yoshimoto, N. Mishina, T. Imaki, K. Naruse, R. Demura, H. Demura, Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats, J. Hypertens. 17 (1999) 53-60.
163. C.D. Fike, M.R. Kaplowitz, Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs, Am. J. Physiol. 277 (1999) L449-L456.
164. J.S. Beckman, W.H. Koppenol, Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly, Am. J. Physiol. 271 (1996) C1424-C1437.
165. S. Ramasamy, G.R. Drummond, J. Ahn, M. Storek, J. Pohl, S. Parthasarathy, D.G. Harrison, Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells, Mol. Pharmacol. 56 (1999) 116-123.
166. R. Heller, F. Munscher Paulig, R. Grabner, U. Till, L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells, J. Biol. Chem. 274 (1999) 8254-8260.
167. T.A. Baker, S. Milstien, Z.S. Katusic, Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells, J. Cardiovasc. Pharmacol. 37 (2001) 333-338.
168. R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, E.R. Werner, L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin, J. Biol. Chem. 276 (2001) 40-47.
169. A. Huang, J.A. Vita, R.C. Venema, J.F. Keaney Jr., Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin, J. Biol. Chem. 275 (2000) 17399-17406.
170. J.M. May, How does ascorbic acid prevent endothelial dysfunction, Free. Radic. Biol. Med. 28 (2000) 1421-1429.
171. J.B. German, R.L. Walzem, The health benefits of wine, Annu. Rev. Nutr. 20 (2000) 561-593.
172. E. Andriambeloson, A.L. Kleschyov, B. Muller, A. Beretz, J.C. Stoclet, R. Andriantsitohaina, Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta, Br. J. Pharmacol. 120 (1997) 1053-1058.
173. M.B. Cishek, M.T. Galloway, M. Karim, J.B. German, C.T. Kappagoda, Effect of red wine on endothelium-dependent relaxation in rabbits, Clin. Sci. (Lond.) 93 (1997) 507-511.
174. M. Flesch, A. Schwarz, M. Bohm, Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries, Am. J. Physiol. 275 (1998) H1183-H1190.
175. T. Wallerath, D. Poleo, H. Li, U. Förstermann, Red wine increases the expression of human endothelial NO synthase (eNOS): A mechanism that may contribute to its beneficial cardiovascular effects, J. Am. Coll. Cardiol. (2002) in press.
176. H. Li, U. Förstermann, Structure-activity relationship of staurosporine analogs in regulating expression of endothelial nitric-oxide synthase gene, Mol. Pharmacol. 57 (2000) 427-435.
177. T. Wallerath, K. Witte, S.C. Schäfer, P.M. Schwarz, W. Prellwitz, P. Wohlfart, H. Kleinert, H.A. Lehr, B. Lemmer, U. Förstermann, Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension, Proc. Natl. Acad. Sci. USA 96 (1999) 13357-13362.
178. Y.K. Lou, C. Wen, M. Li, D.J. Adams, M.X. Wang, F. Yang, B.J. Morris, J.A. Whitworth, Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension, Hypertension 37 (2001) 1164-1170.
179. G.H. Allcock, M. Hukkanen, J.M. Polak, J.S. Pollock, D.M. Pollock, Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats, J. Am. Soc. Nephrol. 10 (1999) 2283-2289.
180. C. Bossaller, U. Forstermann, R. Hertel, C. Olbricht, V. Reschke, E. Fleck, Ciclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production, Eur. J. Pharmacol. 165 (1989) 165-169.
181. G.K. Oriji, H.R. Keiser, Role of nitric oxide in cyclosporine A-induced hypertension, Hypertension 32 (1998) 849-855.
182. N.D. Vaziri, Z. Ni, Y.P. Zhang, E.P. Ruzics, P. Maleki, Y. Ding, Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension, Kidney Int. 54 (1998) 482-491.
183. E.S. Stroes, T.F. Lüscher, F.G. de Groot, H.A. Koomans, T.J. Rabelink, Cyclosporin A increases nitric oxide activity in vivo, Hypertension 29 (1997) 570-575.
184. S. Lopez-Ongil, M. Saura, D. Rodriguez-Puyol, M. Rodriguez-Puyol, S. Lamas, Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells, Am. J. Physiol. 271 (1996) H1072-H1078.
185. J. Navarro-Antolin, J. Rey-Campos, S. Lamas, Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1, J. Biol. Chem. 275 (2000) 3075-3080.
186. N.A. Bobadilla, G. Gamba, E. Tapia, R. Garcia Torres, A. Bolio, P. Lopez Zetina, J. Herrera Acosta, Role of NO in cyclosporin nephrotoxicity: Effects of chronic NO inhibition and NO synthases gene expression, Am. J. Physiol. 274 (1998) F791-F798.
187. J. Navarro-Antolin, O. Hernandez Perera, S. Lopez-Ongil, M. Rodriguez-Puyol, D. Rodriguez-Puyol, S. Lamas, CsA and FK506 up-regulate eNOS expression: Role of reactive oxygen species and AP-1, Kidney Int. Suppl. 68 (1998) S20-S24.
188. Y. Takeda, I. Miyamori, K. Furukawa, S. Inaba, H. Mabuchi, Mechanisms of FK 506-induced hypertension in the rat, Hypertension 33 (1999) 130-136.
189. D. Banerjee, M. Rodriguez, M. Nag, J.W. Adamson, Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity, Kidney Int. 57 (2000) 1895-1904.
190. X.C. Wu, E.J. Johns, N.T. Richards, Relationship between erythropoietin and nitric oxide in the contraction of rat renal arcuate arteries and human umbilical vein endothelial cells, Clin. Sci. Colch. 97 (1999) 413-419.
191. S.L. Lopez-Ongil, M. Saura, S. Lamas, M. Rodriguez-Puyol, D. Rodriguez-Puyol, Recombinant human erythropoietin does not regulate the expression of endothelin-1 and constitutive nitric oxide synthase in vascular endothelial cells, Exp. Nephrol. 4 (1996) 37-42.
192. D. del Castillo, L. Raij, P.J. Shultz, J.P. Tolins, The pressor effect of recombinant human erythropoietin is not due to decreased activity of the endogenous nitric oxide system, Nephrol. Dial. Transplant. 10 (1995) 505-508.
193. H. Tsukahara, M. Hiraoka, C. Hori, I. Hata, T. Okada, F. Gejyo, M. Sudo, Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats, Scand. J. Clin. Lab. Invest. 57 (1997) 487-493.
194. N.D. Vaziri, Z. Ni, F. Oveisi, Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats, Hypertension 31 (1998) 1248-1254.
195. U. Bayraktutan, Z.K. Yang, A.M. Shah, Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat, Cardiovasc. Res. 38 (1998) 719-726.
196. E. Nava, A.L. Farre, C. Moreno, S. Casado, P. Moreau, F. Cosentino, T.F. Lüscher, Alterations to the nitric oxide pathway in the spontaneously hypertensive rat, J. Hypertens. 16 (1998) 609-615.
197. J. Bauersachs, A. Bouloumie, A. Mulsch, G. Wiemer, I. Fleming, R. Busse, Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production, Cardiovasc. Res. 37 (1998) 772-779.
198. A. Wickman, I.J. Andersson, J. Jia, L. Hedin, G. Bergstrom, Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats, J. Hypertens. 19 (2001) 1665-1673.
199. N. Kobayashi, Y. Mori, S. Nakano, Y. Tsubokou, H. Shirataki, H. Matsuoka, Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats, J. Hypertens. 19 (2001) 795-801.
200. N.D. Vaziri, Y. Ding, Z. Ni, Nitric oxide synthase expression in the course of lead-induced hypertension, Hypertension 34 (1999) 558-562.
201. N. Kobayashi, H. Yanaka, A. Tojo, K. Kobayashi, H. Matsuoka, Effects of amlodipine on nitric oxide synthase mRNA expression and coronary microcirculation in prolonged nitric oxide blockade-induced hypertensive rats, J. Cardiovasc. Pharmacol. 34 (1999) 173-181.